erythromycin has been researched along with cefotiam in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 4 (57.14) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arakawa, Y; Kimura, K; Nagano, N; Nagano, Y; Tamai, K; Yanagisawa, H | 1 |
Iwata, S; Murayama, SY; Nakayama, E; Sakata, H; Seki, C; Sunakawa, K; Sunaoshi, K; Ubukata, K | 1 |
Hara, K; Kanda, T; Saito, A; Sawatari, K; Toro, J | 1 |
Funk, A; Gellings, R; Goetz, M; Pütz, I; Winkler, M | 1 |
Biesterfeld, S; Heindrichs, U; Marquet, KL; Rath, W; Winkler, M | 1 |
Baba, S; Hashiba, M; Kozeki, S; Miyamoto, N; Suzuki, K | 1 |
Deguchi, K; Ishihara, R; Ishii, Y; Nakazawa, A; Suzuki, Y | 1 |
7 other study(ies) available for erythromycin and cefotiam
Article | Year |
---|---|
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
Topics: Aminoacyltransferases; Anti-Bacterial Agents; Bacterial Proteins; Female; Genetic Heterogeneity; Humans; Infant, Newborn; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillin Resistance; Penicillin-Binding Proteins; Penicillins; Phylogeny; Sequence Analysis, DNA; Streptococcus agalactiae | 2008 |
Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections.
Topics: Adolescent; Adult; Aged; Bacterial Capsules; Child; Child, Preschool; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Infant; Infant, Newborn; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Polymerase Chain Reaction; Streptococcus agalactiae | 2009 |
New beta-lactamase-resistant cephem treatment of guinea pigs infected with Legionella pneumophila.
Topics: Animals; Cefotaxime; Cefotiam; Ceftazidime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Evaluation, Preclinical; Erythromycin; Guinea Pigs; Legionnaires' Disease; Moxalactam | 1983 |
[Puerperium after threatened premature labor--positive effects of infection screening by determination of CRP in pregnancy].
Topics: Adult; Ampicillin; Anti-Bacterial Agents; C-Reactive Protein; Cefotiam; Drug Therapy, Combination; Endometritis; Erythromycin; Female; Fenoterol; Humans; Infant, Newborn; Infusions, Intravenous; Obstetric Labor, Premature; Pregnancy; Puerperal Infection; Tocolysis | 1994 |
[Incidence of inflammatory placental changes in threatened premature labor with and without additional antibiotic therapy].
Topics: Administration, Intravaginal; Ampicillin; Antibiotic Prophylaxis; Cefotiam; Chorioamnionitis; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythromycin; Female; Fenoterol; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Inflammation; Infusions, Intravenous; Obstetric Labor, Premature; Placenta; Placenta Diseases; Povidone-Iodine; Pregnancy; Tocolysis; Tocolytic Agents | 1997 |
[Study on bacterial biofilm destruction by various antibacterial agents].
Topics: Anti-Bacterial Agents; Biofilms; Cefotiam; Cephalosporins; Clarithromycin; Erythromycin; Miocamycin; Staphylococcus aureus | 1998 |
[Antimicrobial activities of clindamycin against clinical isolated Streptococcus pneumoniae].
Topics: Anti-Bacterial Agents; Cefotiam; Ceftazidime; Cephalosporins; Clindamycin; Drug Resistance, Microbial; Erythromycin; Josamycin; Penicillins; Piperacillin; Streptococcus pneumoniae | 1997 |